Emisphere Technologies Announces Third Quarter 2014 Earnings Conference Call

ROSELAND, N.J., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCQB:EMIS) (the "Company") announced today that Management will host a conference call to discuss the Company's financial and operational results for the three months ended September 30, 2014 on Friday, November 14, 2014 at 8:30 AM ET. A press release will be issued prior to market opening.

The live webcast of the conference call can be accessed through the Company's web site at: www.emisphere.com. The live conference call dial-in number is 1 (877) 303-9483 (United States and Canada) or 1 (760) 666-3584 (International). In addition, an archive of the webcast can be accessed through the same link and an audio replay of the call will be available beginning at 11:30 AM ET on November 14, 2014 through November 27, 2014 by calling 1 (855) 859-2056 (United States and Canada) or 1 (404) 537-3406 (International). The conference replay access # is: 34272613.

About Emisphere Technologies, Inc.

Emisphere Technologies, Inc. is a specialty pharmaceutical company preparing to commence commercial operations. The Company is currently preparing to launch its first prescription product, oral Eligen® B12, in the U.S. Beyond Eligen® B12, the Company utilizes its proprietary Eligen® Technology to create new oral formulations of therapeutic agents. Emisphere is currently partnered with global pharmaceutical companies for the development of new orally delivered therapeutics. For more information, please visit www.emisphere.com.

CONTACT: Alan L. Rubino - CEO 973.532.8100 or arubino@emisphere.com Michael R. Garone - CFO 973.532.8005 or mgarone@emisphere.com

Source:Emisphere Technologies, Inc.